Published in Hospital Business Week, July 29th, 2007
This trend article is an immediate alert from NewsRx to identify the most recent news developments at M. D. Anderson Cancer Center.
Report 1: In the first scientific study of its kind, shark cartilage extract, AE-941 or Neovastat, has shown no benefit as a therapeutic agent when combined with chemotherapy and radiation for patients with advanced non-small cell lung cancer, according to researchers at The University of Texas M. D. Anderson Cancer Center.
Charles Lu, M.D., associate professor in M. D. Anderson's Department of Thoracic/Head and...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hospital Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.